Neuropsychopharmacology
- Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers2 years ago
- Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective2 years ago
- A new prism next to motherhood’s light: uncovering changes in neural function following childbirth2 years ago
- Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry2 years ago
- Basal forebrain-lateral habenula inputs and control of impulsive behavior2 years ago
- Concurrent and longitudinal neurostructural correlates of irritability in children2 years ago
- Distributed circuits regulating defensive state transitions: freezing, flight and fight2 years ago
Journal of Psychopharmacology
- Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice4 years ago
- Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain4 years ago
- Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study4 years ago
- Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report4 years ago
- Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials4 years ago
- The antidepressant effect and safety of non-intranasal esketamine: A systematic review4 years ago
- Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole4 years ago
European Neuropsychopharmacology
- Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment4 years ago
- Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder4 years ago
- Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?4 years ago
- Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders4 years ago
- Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan4 years ago
- The potential of TAAR1 agonists in bipolar disorder4 years ago
- The antipsychotic paradox: Lessons regarding determinants of premature mortality4 years ago